Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Type 2 diabetes")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 8694

  • Page / 348
Export

Selection :

  • and

Type 2 diabetes : Gaining insight into the disease process using proteomicsMARIS, Michael; OVERBERGH, Lut; MATHIEU, Chantal et al.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 3, pp 312-326, issn 1862-8346, 15 p.Article

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithmsCHRISTENSEN, J. O; SANDBAEK, A; LAURITZEN, T et al.Diabetologia (Berlin). 2004, Vol 47, Num 9, pp 1566-1573, issn 0012-186X, 8 p.Article

Trends and Perspectives in the Development of Antidiabetic Drugs for Type 2 Diabetes MellitusLEE, Soo-Hyun; LEE, Jong-Keun; KIM, Ik-Hwan et al.Han'gug mi'saengmul saengmyeong gong haghoeji. 2012, Vol 40, Num 3, pp 180-185, issn 1598-642X, 6 p.Article

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyALMGREN, P; LEHTOVIRTA, M; ISOMAA, B et al.Diabetologia (Berlin). 2011, Vol 54, Num 11, pp 2811-2819, issn 0012-186X, 9 p.Article

Global guideline for type 2 diabetes : recommendations for standard, comprehensive, and minimal careDiabetic medicine. 2006, Vol 23, Num 6, pp 579-593, issn 0742-3071, 15 p.Article

Birthweight of offspring and paternal insulin resistance and paternal diabetes in late adulthood: cross sectional surveyWANNAMETHEE, S. G; LAWLOR, D. A; WHINCUP, P. H et al.Diabetologia (Berlin). 2004, Vol 47, Num 1, pp 12-18, issn 0012-186X, 7 p.Article

Presentation and course of Type 2 diabetes in youth in a large multi-ethnic cityZDRAVKOVIC, V; DANEMAN, D; HAMILTON, J et al.Diabetic medicine. 2004, Vol 21, Num 10, pp 1144-1148, issn 0742-3071, 5 p.Article

Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassayLINDSAY, J. R; MCKILLOP, A. M; MOONEY, M. H et al.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 475-478, issn 0012-186X, 4 p.Article

Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based studyPOUWER, F; BEEKMAN, A. T. F; NIJPELS, G et al.Diabetologia (Berlin). 2003, Vol 46, Num 7, pp 892-898, issn 0012-186X, 7 p.Article

Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studiesCERAS, Javier; CIRAUQUI, Nuria; PEREZ-SILANES, Silvia et al.European journal of medicinal chemistry. 2012, Vol 52, pp 1-13, issn 0223-5234, 13 p.Article

Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and womenHU, G; QIAO, Q; SILVENTOINEN, K et al.Diabetologia (Berlin). 2003, Vol 46, Num 3, pp 322-329, issn 0012-186X, 8 p.Article

Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjectsPÖYKKÖ, S; UKKOLA, O; KAUMA, H et al.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 455-458, issn 0012-186X, 4 p.Article

Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonistBAJARE, Swapnil; ANTHONY, Jessy; NAIR, Amrutha et al.European journal of medicinal chemistry. 2012, Vol 58, pp 355-360, issn 0223-5234, 6 p.Article

Apolipoprotein e4 allele and endothelium-dependent arterial dilation in Type 2 diabetes mellitus without angiopathyGUANGDA, X; YUHUA, W.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 514-519, issn 0012-186X, 6 p.Article

Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meld-analysis of 27 studiesJELLEMA, A; ZEEGERS, M. P. A; FESKENS, E. J. M et al.Diabetologia (Berlin). 2003, Vol 46, Num 7, pp 990-995, issn 0012-186X, 6 p.Article

Sulphonylurea action revisited: the post-cloning eraGRIBBLE, F. M; REIMANN, F.Diabetologia (Berlin). 2003, Vol 46, Num 7, pp 875-891, issn 0012-186X, 17 p.Article

In vitro scan for enhancers at the TCF7L2 locusSAVIC, D; PARK, S. Y; BAILEY, K. A et al.Diabetologia (Berlin). 2013, Vol 56, Num 1, pp 121-125, issn 0012-186X, 5 p.Article

Physical activity and type 2 diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working groupDUCLOS, M; OPPERT, J.-M; VERGES, B et al.Diabetes & metabolism. 2013, Vol 39, Num 3, pp 205-216, issn 1262-3636, 12 p.Article

Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetesMIKUS, C. R; OBERLIN, D. J; LIBLA, J et al.Diabetologia (Berlin). 2012, Vol 55, Num 5, pp 1417-1423, issn 0012-186X, 7 p.Article

The effect of a supported exercise programme in patients with newly diagnosed Type 2 diabetes: A pilot studyBACKX, Karianne; MCCANN, Adrian; WASLEY, David et al.Journal of sports sciences (Print). 2011, Vol 29, Num 6, pp 579-586, issn 0264-0414, 8 p.Article

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemiaSWINNEN, S. G. H. A; MULLINS, P; MILLER, M et al.Diabetologia (Berlin). 2009, Vol 52, Num 1, pp 38-41, issn 0012-186X, 4 p.Article

Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetesSWINNEN, S. G. H. A; DEVRIES, J. H.Diabetologia (Berlin). 2009, Vol 52, Num 11, pp 2324-2327, issn 0012-186X, 4 p.Article

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analysesLASSERSON, D. S; GLASZIOU, P; PERERA, R et al.Diabetologia (Berlin). 2009, Vol 52, Num 10, pp 1990-2000, issn 0012-186X, 11 p.Article

Mutations in the SLC30A8 gene are not a major cause of MODY or other forms of early-onset, autosomal dominant type 2 diabetesBOROWIEC, M; THOMPSON, R; POWERS, C et al.Diabetologia (Berlin). 2007, Vol 50, Num 10, pp 2224-2226, issn 0012-186X, 3 p.Article

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes : results from the Collaborative Atorvastatin Diabetes Study (CARDS)RAIKOU, M; MCGUIRE, A; COLHOUN, H. M et al.Diabetologia (Berlin). 2007, Vol 50, Num 4, pp 733-740, issn 0012-186X, 8 p.Article

  • Page / 348